April 26, 2019 The FDA has approved Eticovo (etanercept-ykro), a biosimilar to U.S.-licensed Enbrel (etanercept). A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an already-FDA approved…Original Article
You may also like
FDA Approves Orlynvah (sulopenem etzadroxil and...
U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for...
Alvotech and Teva Announce U.S. FDA Approval of...
FDA Approves Vyloy (zolbetuximab-clzb) for the...
Botox Cosmetic (onabotulinumtoxinA) Receives FDA...
FDA Approves Vyalev (foscarbidopa and foslevodopa) for...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.